Cardlytics (CDLX) Tops Q3 EPS by 66c

Cardlytics (NASDAQ: CDLX) reported Q3 EPS of $0.01, $0.66 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $79 million versus the consensus estimate of $80.01 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Cheetah Net Supply Chain Service Inc. (CTNT) Reports Q2 EPS of $0.04
• RCM Technologies (RCMT) Tops Q2 EPS by 17c